Rosetta Capital
Finance · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Rectory House Thame Haddenham Rd, Hadden...Phone Number
+44 1844291444Website
www.rosettacapital.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Rosetta Capital
Rosetta Capital is a venture capital firm specializing in life sciences and medical device investments, dedicated to transforming healthcare through strategic funding. The firm empowers entrepreneurs to develop innovative solutions that enhance patient care and improve lives. With over 50 venture investments and extensive experience in executing complex transactions, Rosetta provides flexible liquidity solutions to investors and corporations. Their portfolio includes a range of biotech and pharmaceutical companies, showcasing their commitment to supporting groundbreaking advancements in the healthcare sector.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rosetta Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Rosetta Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Rosetta Capital has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Rosetta Capital launches new products
Check if Rosetta Capital has recently received funding, and reach out quickly before it becomes old news!
Check out if Rosetta Capital is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Rosetta Capital had a recent Job posting/layoffs
Earning: See what the market has to say on Rosetta Capital recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Rosetta Capital
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Rosetta Capital
Compare insights from companies similar to Rosetta Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Rosetta Capital
$7.5M
11-50
Private
-
2001
N/A
Company Profile Activity
Activity Insights
Rosetta Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Rosetta Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Rosetta Capital.
Rosetta Capital Tech Stack
A closer look at the technologies used by Rosetta Capital
Rosetta Capital News & Media
Mission Therapeutics Welcomes Co-founder of Rosetta Capital, Jonathan Hepple, to its Board of Directors
CAMBRIDGE, England--(BUSINESS WIRE)--Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announces the appointment of Jonathan Hepple to the Company’s Board as a Non-Executive Director. Jonathan is joining Mission’s Board of Directors following the purchase of Schroder Adveq’s entire holdings in Mission by Rosetta Capital, of which he is co-founder. The transaction was completed earlier today as part
Read more news
Top Finance Companies
See more top companies
Frequently Asked Questions Regarding Rosetta Capital
Sign Up For FreeTo access detailed company insights
Rosetta Capital is a venture capital firm specializing in life sciences and medical device investments, dedicated to transforming healthcare through strategic funding. The firm empowers entrepreneurs to develop innovative solutions that enhance patient care and improve lives. With over 50 venture investments and extensive experience in executing co... Read More
